News | Hypertension | December 27, 2018

Barbershop Intervention Continues to Lower Blood Pressure at One Year

Reductions in systolic blood pressure observed at 6 months in Cedars-Sinai study were sustained at 12 months

Barbershop Intervention Continues to Lower Blood Pressure at One Year

December 27, 2018 — African-American men participating in a blood pressure reduction program implemented in barbershops continued to have significant improvements in their blood pressure in a twelve-month follow-up study. The research was published in the American Heart Association journal Circulation.1

In the study led by Cedars-Sinai’s Smidt Heart Institute, 52 Los Angeles County barbershops were assigned to either a pharmacist-led intervention or an active control group. In the intervention group, barbers measured blood pressure and promoted follow-up with pharmacists who prescribed blood pressure medication under a collaborative practice agreement with study participants’ primary care providers. In the control group, barbers measured blood pressure and promoted follow-up only with primary care providers and lifestyle modification. At 6 months, the men in the intervention group had significant reductions in their blood pressure compared to those in the control group.

Read the article "Managing Blood Pressure in Barbershops Yields Substantial Improvements" 

After six months, the intervention group continued the program, but had fewer in-person pharmacist visits to test if the intervention effect could be sustained safely for one year while reducing pharmacist travel time to and from barbershops.

When the study began, participants had an average systolic blood pressure of 152.4 mm Hg in the intervention group and 154.6 mm Hg in the control group. Systolic blood pressure is the top number in a blood pressure reading and it measures the pressure the blood exerts against the arteries while the heart is pumping.

At 12 months, the average systolic blood pressure fell by 28.6 mm Hg (to 123.8 mm Hg) in the intervention group and by 7.2 mm Hg (to 147.4 mm Hg) in the control group. The average reduction was 20.8 mm Hg greater with the intervention. These results are indistinguishable from the previously reported 6-month data, which were published in the New England Journal of Medicine.2

The principal investigator for the study was the late Ronald G. Victor, M.D., associate director of the Smidt Heart Institute. In 2010, Victor became the first to prove, through randomized, controlled testing, that barbershop-based health programs could potentially save hundreds of lives annually by helping African American men lower their blood pressure.

Watch the VIDEO: Reducing Hypertension Among African-Americans

For more information: www.ahajournals.org/journal/circ

References

1. Victor R.G., Blyler C.A., Li N., et al. Sustainability of Blood Pressure Reduction in Black Barbershops. Circulation, Dec. 17, 2018. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038165

2. Victor R.G., Lynch K., Li N., et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. New England Journal of Medicine, April 5, 2018. DOI: 10.1056/NEJMoa1717250

Related Content

Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future.

Clinical trial quality data can be derived from national cardiovascular registries, which may change how trials are performed in the future. Getty Images

News | Cardiovascular Clinical Studies | June 24, 2021
June 24, 2021 — Data captured in American College of Cardiology (ACC)...
Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.

Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium. 

News | Cardiovascular Clinical Studies | January 27, 2021
January 27, 2021 — A New York Institute of Technology research te
Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

News | Cardiovascular Clinical Studies | July 22, 2020
July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to re
The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...